2019
DOI: 10.1007/s00266-019-01396-4
|View full text |Cite
|
Sign up to set email alerts
|

BTX-A Rejuvenation: Regional Botulinum Toxin-A Injection of the Platysma in Patients with Facial Sagging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
6
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 5 publications
0
6
0
1
Order By: Relevance
“…BoNT‐A treatment for masseter hypertrophy was slightly more preferred by male patients (58%) in one study 13 . A 62.1% female dominance for BoNT‐A treatment addressing the platysmal bands was observed in a study previously 14 . A previous study showed that there was no difference in terms of gender in the BoNT‐A treatment for hyperhidrosis, both axillary and palmoplantar types 15 .…”
Section: Discussionmentioning
confidence: 89%
See 2 more Smart Citations
“…BoNT‐A treatment for masseter hypertrophy was slightly more preferred by male patients (58%) in one study 13 . A 62.1% female dominance for BoNT‐A treatment addressing the platysmal bands was observed in a study previously 14 . A previous study showed that there was no difference in terms of gender in the BoNT‐A treatment for hyperhidrosis, both axillary and palmoplantar types 15 .…”
Section: Discussionmentioning
confidence: 89%
“…13 A 62.1% female dominance for BoNT-A treatment addressing the platysmal bands was observed in a study previously. 14 A previous study showed that there was no difference in terms of gender in the BoNT-A treatment for hyperhidrosis, both axillary and palmoplantar types. 15 To our knowledge, ours is the first study to determine the gender prevalences according to the treatment area, and we report that there is no treatment area preference in terms of gender.…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…2 At present, plastic surgery clinical treatment of facial wrinkles mainly use Botulinum Toxin A injection method. 3 Botulinum Toxin A acts on the peripheral motor nerve endings, inhibits the release of acetylcholine from presynaptic membrane, relaxes local muscles, and exerts wrinkles removal effect. 4 It has been found that mexiletine also relaxes the striated muscles and has good antioxidant properties.…”
mentioning
confidence: 99%
“…Facial expression muscle contraction and facial skin aging and relaxation are the main causes of facial wrinkles 2 . At present, plastic surgery clinical treatment of facial wrinkles mainly use Botulinum Toxin A injection method 3 . Botulinum Toxin A acts on the peripheral motor nerve endings, inhibits the release of acetylcholine from presynaptic membrane, relaxes local muscles, and exerts wrinkles removal effect 4 .…”
mentioning
confidence: 99%